NeutraHealth says Elders offer likely to be in cash UK-based NeutraHealth Plc confirmed on Monday that the unsolicited offer approach from Indias Elder Pharmaceuticals Ltd at an indicative price of 5.5 pence per share was likely to be solely in cash. On Feb. 27, the distributor of vitamins, supplements and alternative remedies had said a potential deal could raise Elders stake in the company to between 50 percent and 60 percent from 21 percent. NeutraHealth, which delayed releasing its results following the offer approach, had also said it expected 2008 revenue to be about 28.9 million pounds ($41.37 million), with earning before interest, taxes, depreciation and amortization, before one off items, of 1.9 million pounds. Elder Pharmaceuticals FZCO, the Dubai-based unit of Elder, had proposed the offer. Shares of the company were indicated down about 5 percent at 5 pence at 0739 GMT

<< Back